Injection to prevent preeclampsia in high-risk pregnancy
Part of Women’s health & pregnancy clinical trials.
This study tests whether an injection of a medicine called topefilgrastim can help prevent a serious pregnancy complication called preeclampsia in women who are at high risk. If you are early in pregnancy (11-13 weeks), you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between the ages of 18 and 45.
- You must be between 11 and 13 weeks pregnant with a single baby at the time you join.
- You must have been identified as high risk for preeclampsia based on a special blood test or ultrasound assessment.
- You cannot have active infections like HIV, hepatitis B, hepatitis C, or syphilis.
- You cannot have a known allergy to the study drug or similar medications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This study is testing a new treatment strategy for women with preeclampsia, a serious pregnancy condition that causes high blood pressure. If you have preeclampsia or a normal pregnancy, you may be able to join to help find better treatments.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This trial tests if taking progesterone early in pregnancy can help prevent preeclampsia, a condition of high blood pressure. You may qualify if you are over 18, speak English, and are less than 12 weeks pregnant.
Hear when a new Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.